Life ScienceCompany
Rosetta Genomics M&A Summary
Rosetta Genomics has acquired 1 company of its own. It has also divested 1 asset.
Rosetta Genomics’ largest acquisition to date was in 2015, when it acquired CynoGen for $2M. It’s largest disclosed sale occurred in 2018, when it sold CynoGen to Genoptix for $1M. Rosetta Genomics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Rosetta Genomics Ownership
Who owns Rosetta Genomics?
Rosetta Genomics is owned by Genoptix. It was acquired on December 15, 2017.
Rosetta Genomics Business Overview
Where is Rosetta Genomics headquartered?
Rosetta Genomics is headquartered in Rehovot, Israel.
How many employees does Rosetta Genomics have?
Rosetta Genomics has 52 employees.
What sector is Rosetta Genomics in?
Rosetta Genomics is a life science company.
When was Rosetta Genomics founded?
Rosetta Genomics was founded in 2000.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
Unlimited Searches
